Back to companies
Aquestive Therapeutics, Inc.
AQSTUSNASDAQPharmaceuticals & HealthcareAquestive Therapeutics, Inc.
Revenue
$44.5mn
YoY -22.6%
Operating income
-$71.1mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API